BiotechTube
Home/Engimmune Therapeutics/Thomas Sandal
TS

Thomas Sandal

Head of CMC

Engimmune Therapeutics

Therapeutic Areas

OncologyAutoimmune Diseases

Engimmune Therapeutics Pipeline

DrugIndicationPhase
Lead Asset (undisclosed)Solid TumorsPreclinical

Leadership Team at Engimmune Therapeutics

LN
Lars Nieba, PhD
CEO
RV
Rodrigo Vazquez-Lombardi, PhD
Co-Founder & CSO
KC
Kenneth Crook, PhD
Head of Translational Medicine
SR
Sai Reddy, PhD
Co-Founder, Chairman of SAB
View full Engimmune Therapeutics profile